Geron | GERN - Ebit

Stock Price
1.30
Daily Change
-0.11 -7.50%
Monthly
-23.37%
Yearly
1.97%
Q2 Forecast
1.36

Geron reported $-236K in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Amgen USD 3.83B 130M Mar/2026
Bio Techne USD 75.49M 21.03M Mar/2026
Cassava Sciences USD -13.55M 1.69M Dec/2025
Cytokinetics USD -181.23M 2.86M Mar/2026
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Exelixis USD 251.34M 15.43M Mar/2026
Genmab DKK 260M 199M Dec/2025
Geron USD -236K 10.55M Mar/2026
Gilead Sciences USD 2.68B 284M Mar/2026
Incyte USD 344.17M 39.71M Mar/2026
MacroGenics USD -12.1M 32.26M Dec/2025
Novartis USD 4.18B 118M Mar/2026
Novavax USD 20.94M 100.32M Dec/2025